ArTS Archivio della ricerca di Trieste

POZZATO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.601
EU - Europa 7.759
AS - Asia 2.412
AF - Africa 33
SA - Sud America 28
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 18
Totale 25.876
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.517
PL - Polonia 1.766
UA - Ucraina 1.563
SE - Svezia 1.193
IT - Italia 1.098
CN - Cina 691
SG - Singapore 659
HK - Hong Kong 589
FI - Finlandia 481
DE - Germania 389
IE - Irlanda 281
BG - Bulgaria 276
TR - Turchia 256
GB - Regno Unito 211
FR - Francia 162
CA - Canada 77
RU - Federazione Russa 75
CH - Svizzera 65
BE - Belgio 53
IN - India 46
JP - Giappone 37
VN - Vietnam 36
NL - Olanda 30
AU - Australia 21
KR - Corea 21
PK - Pakistan 20
RO - Romania 19
CZ - Repubblica Ceca 18
IR - Iran 18
ES - Italia 16
EU - Europa 14
SN - Senegal 14
BR - Brasile 13
EG - Egitto 12
TW - Taiwan 10
PT - Portogallo 9
GR - Grecia 8
LU - Lussemburgo 8
CL - Cile 7
HR - Croazia 7
MX - Messico 7
AT - Austria 6
IL - Israele 6
DK - Danimarca 5
NO - Norvegia 5
PH - Filippine 5
NZ - Nuova Zelanda 4
ZA - Sudafrica 4
AR - Argentina 3
BD - Bangladesh 3
EE - Estonia 3
LT - Lituania 3
SA - Arabia Saudita 3
A1 - Anonimo 2
BY - Bielorussia 2
CO - Colombia 2
HU - Ungheria 2
ID - Indonesia 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
PE - Perù 2
RS - Serbia 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
BF - Burkina Faso 1
EC - Ecuador 1
IM - Isola di Man 1
JO - Giordania 1
KW - Kuwait 1
MK - Macedonia 1
SI - Slovenia 1
Totale 25.876
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.961
Ann Arbor 1.821
Warsaw 1.757
Fairfield 1.530
Jacksonville 1.392
Houston 1.367
Chandler 1.253
Ashburn 898
Wilmington 875
Hong Kong 583
Seattle 570
Princeton 536
Singapore 521
Cambridge 503
Boardman 430
Trieste 321
Dublin 277
Sofia 276
Columbus 262
Izmir 238
Beijing 224
Dearborn 101
San Diego 97
Santa Clara 67
Düsseldorf 64
Redwood City 59
Bern 56
Milan 55
Chicago 50
Brussels 46
Toronto 41
Norwalk 40
Verona 40
Buffalo 33
Helsinki 33
Phoenix 32
Dong Ket 30
Shanghai 30
Des Moines 28
Kunming 27
Sacile 27
Jinan 26
Los Angeles 26
Mestre 26
Ottawa 25
Falls Church 24
Nanjing 23
Padova 23
Hefei 22
Duino-Aurisina 21
Grafing 21
Guangzhou 20
Washington 20
Venezia 18
Munich 17
Seoul 17
Bremen 16
Dakar 14
Brno 13
Fremont 13
Redmond 13
Shenyang 13
Kamiikebukuro 12
Fuzhou 11
Amsterdam 10
Indiana 10
Lahore 10
London 10
Hebei 9
Mumbai 9
Udine 9
Zhengzhou 9
Hangzhou 8
New York 8
Tainan City 8
Timisoara 8
Tokyo 8
Venice 8
Dongguan 7
Horia 7
Kocaeli 7
Leawood 7
Shenzhen 7
São Paulo 7
Taiyuan 7
Antwerpen 6
Auburn Hills 6
Dallas 6
Lublin 6
Monfalcone 6
Rome 6
San Francisco 6
Villa San Giovanni 6
Frankfurt am Main 5
Madrid 5
Nanchang 5
Naples 5
Pune 5
Stockholm 5
Surat 5
Totale 19.241
Salva come PNG Salva come JPEG
Nome #
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 381
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 377
Potential applications of nanocellulose-containing materials in the biomedical field 364
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies 350
Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options. 339
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: Evidence for a NOTCH1 mutation-driven epigenetic dysregulation 316
Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines 311
Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt's lymphoma: a case report and review of the literature 280
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival 263
Mutations in the 3' untranslated region (3' UTR) of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 257
Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases 251
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 231
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 211
The role of the transcription factor E2F1 in hepatocellular carcinoma 211
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 198
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application. 181
Translation Elongation 178
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 178
Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry. 175
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components 174
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 168
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 167
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism. 164
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 163
Metastatic angioimmunoblastic T-cell lymphoma started from thoracic paravertebral region: a Case report 163
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia. 162
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia 162
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 157
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 157
Impact of DEFB1 gene regulatory polymorphisms on hBD-1 salivary concentration 154
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 153
null 150
Introduction 147
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 144
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 140
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells 140
ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles ofTP53disrupted chronic lymphocytic leukaemia cells 139
Improving siRNA Bio-Distribution and Minimizing Side Effects 139
Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands? 139
Hematologic problems in the Critically III 136
No evidence of Polyomavirus and EBV infections in Italian patients with mixed cryoglobulinemia infected chronically with HCV 136
S-adenosylmethionine counteracts oral contraceptive hepatotoxicity in women 135
Influence of acid-secretion blockers on gastric and hepatic alcohol dehydrogenase in rat 135
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 134
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 134
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 132
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia. 131
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage. 130
A case of burkitt-like B lymphoblastic lymphoma 129
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 129
Randomized trial of combination therapy in relapser or non-responder HCV patients 127
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 125
DEFB1 polymorphisms and salivary hBD-1 concentration in Oral Lichen Planus patients and healthy subjects 124
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 123
Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials 122
A new genotype: typical of Italy? 121
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells 120
null 119
null 119
Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. 118
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 117
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: relationship to the severity of liver disease and response to the alpha-interferon therapy. 116
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 115
Merkel-cell polyomavirus and B-cell chronic lymphocytic leukemia 114
Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas 114
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 114
Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. 113
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 111
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 111
Gastric and hepatic glutathione after ethanol load: the role of first-pass metabolism and effects of antisecretive drugs. 110
A randomized trial comparing different alfa-interferon at different dose and duration as therapy for chronic hepatitis C. 110
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 109
null 108
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia. 108
Acute high-dose ethanol modulates glutathione levels to different degrees in various organs of the rat. 107
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells 107
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 106
Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction. 106
A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B 106
Merkel-cell polyomavirus (MCPyV) is rarely associated to B-chronic lymphocytic leukemia (1 out of 50) samples and occurs late in the natural history of the disease. 106
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 106
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 106
null 105
Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. 104
Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. 104
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 104
Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. 104
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. 104
Etiologic treatment of hepatitis C virus-associated mixed cryoglobulinemia. 102
MDM4 (MDMX) is overexpressed in chronic lymphocytic leukaemia (CLL) and marks a subset of p53wild-type CLL with a poor cytotoxic response to Nutlin-3 102
Abnormal serum gamma-glutamyltranspeptidase in alcoholics: clues to its explanation 102
A transient cutaneous relapse of AML M1 in hematological remission: A case report 102
Prevalence of markers of autoimmunity and correlation with HCV genotypes and chronic liver disease in the general population of Northern Italy 100
Cirrhotic thrombocytopenia is a multifactorial condition: evidence of reduced platelet production and incresed platelet destruction 100
HEPATIC GLUTATHIONE AFTER ETHANOL ADMINISTRATION IN RAT: EFFECTS OF CIMETIDINE AND OMEPRAZOLE. 99
ALCOHOL HEPATIC TOXICITY IN RAT: EVIDENCE OF THE UTILITY OF THE GASTRIC ETHANOL METABOLISM 99
Hepatic glutathione determination after ethanol administration in rat: evidence of the first-pass metabolism of ethanol. 99
Unconjugated hyperbilirubinemia in HBV carriers. Discriminant value of nicotinic acid (NA) test 99
Typing core region of hepatitis C virus by polymerase chain reaction: results from North East of Italy 99
LYMPHOCYTE SUBSETS IN HCV POSITIVE CHRONIC LIVER DISEASE. 98
Totale 15.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.557
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.036 0 0 0 0 0 622 493 606 387 287 412 229
2020/20213.794 399 195 421 541 241 424 146 353 127 437 119 391
2021/20222.722 71 235 151 344 42 156 100 139 367 304 166 647
2022/20233.443 376 378 295 454 374 646 29 263 406 36 125 61
2023/20242.013 165 132 84 98 159 154 296 503 21 63 162 176
2024/20251.385 117 144 308 392 412 12 0 0 0 0 0 0
Totale 26.461